- Home
- CRMD vs PAXS Comparison
CRMD vs PAXS Comparison
Compare CRMD & PAXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CRMD | PAXS |
|---|---|---|
| Founded | 2006 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 590.7M | 664.0M |
| IPO Year | 2009 | 2021 |
Fundamental Metrics
Financial Performance| Metric | CRMD | PAXS |
|---|---|---|
| Price | $7.90 | $13.27 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $14.83 | N/A |
| AVG Volume (30 Days) | ★ 759.2K | 278.9K |
| Earning Date | 05-11-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 780.00 | N/A |
| EPS | ★ 0.72 | N/A |
| Revenue | ★ $311,709,000.00 | N/A |
| Revenue This Year | $0.30 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $10.79 | ★ N/A |
| Revenue Growth | ★ 617.03 | N/A |
| 52 Week Low | $6.13 | $12.92 |
| 52 Week High | $13.02 | $16.56 |
Technical Indicators
Market Signals| Indicator | CRMD | PAXS |
|---|---|---|
| Relative Strength Index (RSI) | 47.85 | 34.93 |
| Support Level | $7.09 | N/A |
| Resistance Level | $9.01 | $14.85 |
| Average True Range (ATR) | 0.23 | 0.20 |
| MACD | -0.03 | -0.04 |
| Stochastic Oscillator | 32.10 | 25.85 |
Price Performance
Historical ComparisonAbout CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.
About PAXS PIMCO Access Income Fund of Beneficial Interest
PIMCO Access Income Fund is a non-diversified, limited-term, closed-end management investment company. The fund seeks current income as an objective and capital appreciation as a secondary objective. It achieves the investment objectives by utilizing a dynamic asset allocation among multiple sectors in the public and private credit markets, including corporate debt.